Author

Melissa K. Thomas

Observed names: M K Thomas, M Thomas, M. K. Thomas, M.K. Thomas, MELISSA K. THOMAS, MELISSA THOMAS, Melissa K Thomas, Melissa Thomas, Melissa K. Thomas, Thomas, Melissa K.

Institution: Eli Lilly (United States)

Observed institutions: Lyon 1 Université, Broad Institute, University of Minnesota, Howard Hughes Medical Institute, Harvard University, Inserm, Eli Lilly (United States), Vanderbilt University, Washington University in St. Louis, Massachusetts General Hospital, Laboratoire de recherche en cardiovasculaire, métabolisme, diabétologie et nutrition, National Cancer Institute, Profil Institute for Metabolic Research, Vanderbilt University Medical Center

ORCID: 0000-0001-9848-2834

Observed ORCID: 0000-0001-9848-2834

OpenAlex ID: A5013110210

Hypovitaminosis D in Medical Inpatients

1998 · Melissa K. Thomas, Donald M. Lloyd-Jones, et al. · New England Journal of Medicine · 1,423

PDF

Multipotential Nestin-Positive Stem Cells Isolated From Adult Pancreatic Islets Differentiate Ex Vivo Into Pancreatic Endocrine, Exocrine, and Hepatic Phenotypes

2001 · Henryk Zulewski, Elizabeth J. Abraham, et al. · Diabetes · 785

PDF

A reference map of potential determinants for the human serum metabolome

2020 · Noam Bar, Tal Korem, et al. · Nature · 448

Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA

2023 · Julio Rosenstock, Juan Frias, et al. · The Lancet · 414

Minireview: Transcriptional Regulation in Pancreatic Development

2004 · Joel F. Habener, Daniel M. Kemp, et al. · Endocrinology · 399

Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes

2020 · Melissa K Thomas, Amir Nikooienejad, et al. · The Journal of Clinical Endocrinology & Metabolism · 341

LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept

2022 · Tamer Coskun, Shweta Urva, et al. · Cell Metabolism · 311

PDF

Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial

2024 · Arun J. Sanyal, Lee M. Kaplan, et al. · Nature Medicine · 304

Creatine Increases Survival and Delays Motor Symptoms in a Transgenic Animal Model of Huntington's Disease

2001 · Ole A. Andreassen, Alpaslan Dedeoglu, et al. · Neurobiology of Disease · 293

Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial

2022 · Tim Heise, Andrea Mari, et al. · The Lancet Diabetes & Endocrinology · 244

Characterization of a purified bovine lung cGMP-binding cGMP phosphodiesterase.

1990 · M.K. Thomas, S.H. Francis, et al. · Journal of Biological Chemistry · 226

Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 Diabetes

2023 · Tim Heise, J. Hans DeVries, et al. · Diabetes Care · 208

PDF

LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial

2022 · Shweta Urva, Tamer Coskun, et al. · The Lancet · 201

A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes

2018 · Natalie R. van Zuydam, Emma Ahlqvist, et al. · Diabetes · 195

PDF

The structure of a bovine lung cGMP-binding, cGMP-specific phosphodiesterase deduced from a cDNA clone.

1993 · L.M. McAllister-Lucas, W.K. Sonnenburg, et al. · Journal of Biological Chemistry · 169

Substrate- and kinase-directed regulation of phosphorylation of a cGMP-binding phosphodiesterase by cGMP.

1990 · M.K. Thomas, S.H. Francis, et al. · Journal of Biological Chemistry · 162

FSTL3 deletion reveals roles for TGF-β family ligands in glucose and fat homeostasis in adults

2007 · Abir Mukherjee, Yisrael Sidis, et al. · Proceedings of the National Academy of Sciences · 157

Hedgehog signaling regulation of insulin production by pancreatic beta-cells.

2000 · M K Thomas, N Rastalsky, et al. · Diabetes · 153

PDF

Muscle sphingolipids during rest and exercise: a C18:0 signature for insulin resistance in humans

2016 · Bryan C. Bergman, Joseph T. Brozinick, et al. · Diabetologia · 145

PDF

Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials

2022 · Adem Y Dawed, Andrea Mari, et al. · The Lancet Diabetes & Endocrinology · 131

PDF

Tirzepatide modulates the regulation of adipocyte nutrient metabolism through long-acting activation of the GIP receptor

2024 · Ajit Regmi, Eitaro Aihara, et al. · Cell Metabolism · 130

The Type 2 Diabetes Knowledge Portal: An open access genetic resource dedicated to type 2 diabetes and related traits

2023 · Maria C. Costanzo, Marcin von Grotthuss, et al. · Cell Metabolism · 128

PDF

Stromal Cell–Derived Factor-1 (SDF-1)/CXCL12 Attenuates Diabetes in Mice and Promotes Pancreatic β-Cell Survival by Activation of the Prosurvival Kinase Akt

2007 · Tatsuya Yano, Zhengyu Liu, et al. · Diabetes · 127

PDF

Alginate Encapsulant Incorporating CXCL12 Supports Long-Term Allo- and Xenoislet Transplantation Without Systemic Immune Suppression

2015 · T. Chen, J. Yuan, et al. · American Journal of Transplantation · 125

Circulating FGF21 proteolytic processing mediated by fibroblast activation protein

2015 · Eugene Y. Zhen, Zhaoyan Jin, et al. · Biochemical Journal · 123

Works count: 106

Citation count: 7,003

H-index: 38

I10-index: 60